Jefferies Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.46M | Buy |
+10,900
| New | +$2.64M | 0.02% | 536 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$2.13M | – | 1606 |
|
|
2021
Q3 | $2.13M | Buy |
+10,000
| New | +$2.3M | 0.02% | 740 |
|
|
2021
Q1 | – | Sell |
-17,500
| Closed | -$4.02M | – | 1602 |
|
|
2020
Q4 | $4.02M | Hold |
17,500
| – | – | 0.03% | 479 |
|
|
2020
Q3 | $4.45M | Buy |
17,500
+6,800
| +64% | +$1.68M | 0.05% | 318 |
|
|
2020
Q2 | $2.52K | Sell |
10,700
-16,100
| -60% | -$3.67M | 0.03% | 476 |
|
|
2020
Q1 | $5.59M | Sell |
26,800
-39,100
| -59% | -$8.54M | 0.06% | 282 |
|
|
2019
Q4 | $15.9M | Buy |
65,900
+8,400
| +15% | +$1.85M | 0.12% | 145 |
|
|
2019
Q3 | $11.1M | Sell |
57,500
-372,500
| -87% | -$71.5M | 0.09% | 187 |
|
|
2019
Q2 | $79.2M | Buy |
+430,000
| New | +$77M | 0.58% | 14 |
|
|
2019
Q1 | – | Sell |
-15,400
| Closed | -$3M | – | 2291 |
|
|
2018
Q4 | $3M | Sell |
15,400
-11,200
| -42% | -$2.19M | 0.02% | 632 |
|
|
2018
Q3 | $5.51M | Buy |
26,600
+8,400
| +46% | +$1.66M | 0.04% | 499 |
|
|
2018
Q2 | $3.36M | Sell |
18,200
-12,800
| -41% | -$2.26M | 0.02% | 648 |
|
|
2018
Q1 | $5.29M | Buy |
31,000
+29,500
| +1,967% | +$5.42M | 0.03% | 444 |
|
|
2017
Q4 | $261K | Sell |
1,500
-54,500
| -97% | -$9.65M | ﹤0.01% | 2079 |
|
|
2017
Q3 | $10.4M | Buy |
56,000
+40,400
| +259% | +$7.16M | 0.07% | 263 |
|
|
2017
Q2 | $2.69M | Sell |
15,600
-47,600
| -75% | -$7.74M | 0.02% | 814 |
|
|
2017
Q1 | $10.4M | Buy |
63,200
+29,600
| +88% | +$4.92M | 0.08% | 251 |
|
|
2016
Q4 | $4.91M | Sell |
33,600
-3,700
| -10% | -$557K | 0.03% | 573 |
|
|
2016
Q3 | $6.22M | Buy |
37,300
+35,600
| +2,094% | +$6.02M | 0.03% | 456 |
|
|
2016
Q2 | $259K | Sell |
1,700
-7,700
| -82% | -$1.2M | ﹤0.01% | 1710 |
|
|
2016
Q1 | $1.41M | Sell |
9,400
-17,900
| -66% | -$2.66M | 0.01% | 996 |
|
|
2015
Q4 | $4.43M | Sell |
27,300
-32,800
| -55% | -$5.16M | 0.03% | 526 |
|
|
2015
Q3 | $8.31M | Buy |
60,100
+52,000
| +642% | +$8.2M | 0.05% | 312 |
|
|
2015
Q2 | $1.24M | Buy |
+8,100
| New | +$1.3M | 0.01% | 1147 |
|
|
2015
Q1 | – | Sell |
-48,500
| Closed | -$7.73M | – | 2056 |
|
|
2014
Q4 | $7.73M | Hold |
48,500
| – | – | 0.05% | 307 |
|
|
2014
Q3 | $6.81M | Hold |
48,500
| – | – | 0.05% | 333 |
|
|
2014
Q2 | $5.74M | Buy |
+48,500
| New | +$5.61M | 0.05% | 324 |
|
|
2013
Q4 | – | Sell |
-93,400
| Closed | -$10.5M | – | 1897 |
|
|
2013
Q3 | $10.5M | Buy |
+93,400
| New | +$10.1M | 0.1% | 170 |
|
Other funds holding AMGN
Jefferies Group's AMGN Position: Q3 2022 in Review
Jefferies Group increased its Amgen (AMGN) stake by 3,672% in Q3 2022, buying an estimated $17.8M and bringing the position to 75,480 shares worth $17M. The position accounts for 0.14% of the portfolio, ranked #112.
Jefferies Group first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Jefferies Group held 75,480 shares of Amgen worth $17M as of Q3 2022.
- Jefferies Group bought 73,479 Amgen shares in Q3 2022, an estimated $17.8M.
- Amgen made up 0.14% of Jefferies Group's portfolio in Q3 2022, its #112 holding.
- Jefferies Group first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Jefferies Group's Amgen position peaked at $48.6M in Q2 2021.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.